Using microscopy and 3D imaging, they were able to examine the fossils’ minute details. It revealed they had spinnerets and ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Soon AI agents will be writing better, cleaner code than any mere human can, just like compilers can write better assembly. There’s an old joke about the weather in San Francisco: If you don’t like it ...

Ms. O’Rourke is the executive editor of The Yale Review and a professor of creative writing at Yale University. July 18, 2025 When I first told ChatGPT who I was, it sent a gushing reply: “Oh wow — it ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

The Dress to Impress developers have brought back a limited-time item that many players will be happy to see temporarily returning, the Old Mermaid Tail. This is part of the 2025 Summer Update where ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

The fundamental design principles behind rotary-wing aircraft date back to the Renaissance, with some of the earliest-known designs belonging to Leonardo da Vinci. Naturally, technology has ...

Recursion Pharmaceuticals' stock has plummeted 57% since February, with significant failures in its lead drug REC-994 and other clinical candidates, raising concerns about its AI-driven drug discovery ...